NYSE:KEYS
Keysight Technologies Inc Stock News
$150.21
+1.66 (+1.12%)
At Close: Apr 29, 2024
How these 22 tech stocks stand out from the pack this earnings season
03:32pm, Monday, 14'th Nov 2022 MarketWatch
Companies including Electronic Arts, ON Semiconductor and Fiserv pulled off a difficult feat in a down cycle --- improving sales and profit margins.
Will Higher Revenues Benefit Keysight (KEYS) Q4 Earnings?
12:10pm, Monday, 14'th Nov 2022 Zacks Investment Research
Keysight (KEYS) is expected to have recorded year-over-year higher revenues in fiscal fourth quarter due to increased sales from both the operating segments.
Will Higher Revenues Benefit Keysight (KEYS) Q4 Earnings?
08:17am, Monday, 14'th Nov 2022
Keysight (KEYS) is expected to have recorded year-over-year higher revenues in fiscal fourth quarter due to increased sales from both the operating segments.
Keysight (KEYS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
03:00pm, Thursday, 10'th Nov 2022 Zacks Investment Research
Keysight (KEYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This Under-the-Radar Tech Stock Is Crushing the Market, and It Is Still a Bargain
11:25am, Tuesday, 08'th Nov 2022 The Motley Fool
Investors should consider buying this stock while it is still cheap.
This Under-the-Radar Tech Stock Is Crushing the Market, and It Is Still a Bargain
06:25am, Tuesday, 08'th Nov 2022
Investors should consider buying this stock while it is still cheap.
Keysight (KEYS) Stock Sinks As Market Gains: What You Should Know
10:50pm, Monday, 07'th Nov 2022 Zacks Investment Research
Keysight (KEYS) closed the most recent trading day at $163.52, moving -0.2% from the previous trading session.
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
02:13pm, Thursday, 03'rd Nov 2022 Benzinga
Upgrades
According to Baird, the prior rating for Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) was changed from Neutral to Outperform. Ultragenyx Pharmaceutical earned $2.43 in the third quarter, comp
Keysight Technologies: A Profitable Pick-And-Shovel Choice For The Fans Of Tech
10:51am, Thursday, 03'rd Nov 2022
Keysight Technologies is a major player in the communications testing and measurement market. Keysight undertakes risky R&D projects and does so without sacrificing bottom line margins.
Keysight (KEYS) Dips More Than Broader Markets: What You Should Know
09:50pm, Monday, 31'st Oct 2022 Zacks Investment Research
In the latest trading session, Keysight (KEYS) closed at $174.15, marking a -1.97% move from the previous day.
Keysight Technologies to Host Webcast of Fourth Quarter Fiscal Year 2022 Earnings Conference Call
08:01am, Thursday, 27'th Oct 2022
SANTA ROSA, Calif.
Keysight (KEYS) Gains But Lags Market: What You Should Know
10:00pm, Monday, 24'th Oct 2022 Zacks Investment Research
In the latest trading session, Keysight (KEYS) closed at $169.40, marking a +0.26% move from the previous day.
Keysight (KEYS) Outpaces Stock Market Gains: What You Should Know
10:00pm, Tuesday, 18'th Oct 2022 Zacks Investment Research
Keysight (KEYS) closed the most recent trading day at $161.20, moving +1.31% from the previous trading session.
Keysight Is Positioned To Profit From Secular Growth Markets
05:21pm, Tuesday, 18'th Oct 2022
Keysight Technologies, Inc. shares have held in relatively well this year and offer an attractive GARP opportunity at 19x earnings. Results have been excellent with stronger orders than deliveries as
The Zacks Analyst Blog Highlights Perion Network, Keysight Technologies, Arista Networks and Agilent Technologies
11:00am, Tuesday, 18'th Oct 2022 Zacks Investment Research
Perion Network, Keysight Technologies, Arista Networks and Agilent Technologies are included in this Analyst Blog.